Sorich Foils Ltd
₹
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 8.58 %
- ROE 5.98 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has a low return on equity of 6.13% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 26.74 | 24.40 | 17.64 | 15.83 | 12.93 | 18.01 | 40.00 | |
| 25.18 | 22.90 | 17.04 | 14.93 | 12.33 | 15.00 | 36.96 | |
| Operating Profit | 1.56 | 1.50 | 0.60 | 0.90 | 0.60 | 3.01 | 3.04 |
| OPM % | 5.83% | 6.15% | 3.40% | 5.69% | 4.64% | 16.71% | 7.60% |
| 0.03 | 0.10 | 0.55 | 0.03 | 0.20 | 0.09 | 0.11 | |
| Interest | 1.19 | 1.06 | 0.72 | 0.60 | 0.63 | 0.70 | 0.74 |
| Depreciation | 0.25 | 0.38 | 0.32 | 0.28 | 0.24 | 0.21 | 0.18 |
| Profit before tax | 0.15 | 0.16 | 0.11 | 0.05 | -0.07 | 2.19 | 2.23 |
| Tax % | 53.33% | 37.50% | -18.18% | 40.00% | 28.57% | 30.14% | 30.04% |
| 0.07 | 0.11 | 0.13 | 0.03 | -0.09 | 1.53 | 1.56 | |
| EPS in Rs | 0.12 | 0.19 | 0.22 | 0.05 | -0.15 | 2.62 | 2.67 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 36% |
| TTM: | 122% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 70% |
| 3 Years: | 273% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 6% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 5.83 | 5.83 | 5.83 | 5.83 | 6.23 | 8.05 | 15.27 |
| Reserves | 3.98 | 4.09 | 3.32 | 3.35 | 3.46 | 9.10 | 19.75 |
| 9.00 | 6.90 | 6.90 | 4.18 | 4.95 | 10.57 | 6.52 | |
| 6.31 | 10.05 | 3.87 | 7.18 | 15.82 | 10.75 | 7.28 | |
| Total Liabilities | 25.12 | 26.87 | 19.92 | 20.54 | 30.46 | 38.47 | 48.82 |
| 1.73 | 2.32 | 1.99 | 1.71 | 1.48 | 1.28 | 5.61 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 5.48 | 5.16 | 5.72 | 5.72 | 5.72 | 7.26 | 5.72 |
| 17.91 | 19.39 | 12.21 | 13.11 | 23.26 | 29.93 | 37.49 | |
| Total Assets | 25.12 | 26.87 | 19.92 | 20.54 | 30.46 | 38.47 | 48.82 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0.50 | 4.32 | 1.36 | 2.90 | -0.69 | 0.07 | -6.31 | |
| -0.95 | 0.97 | -0.89 | 0.00 | 0.00 | -0.01 | -2.88 | |
| 0.41 | 0.40 | -0.63 | -2.42 | 0.73 | 0.05 | 11.53 | |
| Net Cash Flow | -0.04 | 5.70 | -0.16 | 0.48 | 0.04 | 0.10 | 2.34 |
| Free Cash Flow | -0.48 | 5.29 | 1.38 | 2.90 | -0.69 | 0.06 | -10.82 |
| CFO/OP | 36% | 290% | 230% | 322% | -110% | 25% | -185% |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 110.16 | 124.61 | 88.15 | 71.25 | 130.14 | 111.87 | 89.33 |
| Inventory Days | 126.21 | 131.27 | 154.30 | 221.51 | 573.47 | 573.14 | 247.19 |
| Days Payable | 83.37 | 126.90 | 85.09 | 149.90 | 457.73 | 245.00 | 62.48 |
| Cash Conversion Cycle | 152.99 | 128.97 | 157.35 | 142.85 | 245.88 | 440.01 | 274.04 |
| Working Capital Days | 72.89 | 52.36 | 50.90 | 53.49 | 88.64 | 265.29 | 193.08 |
| ROCE % | 6.85% | 5.05% | 4.42% | 4.00% | 13.64% | 8.58% |
Insights
In beta| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | May 2018 | |
|---|---|---|---|---|---|---|
| Actual Production Volume MT |
|
|||||
| Capacity Utilization % |
||||||
| Installed Capacity MT per annum |
||||||
| Revenue Concentration from Top 10 Customers % |
||||||
| Revenue Contribution from Pharmaceutical Sector % |
||||||
| Regional Concentration (Western India) % |
||||||
| Number of Major Product Variants Number |
||||||
| Workforce (Total Employees) Number |
||||||
Requires Premium
Requires Premium